Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

A new protein linked to Alzheimer's was discovered, and a hair loss treatment showed effectiveness but had some sexual side effects.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

Finasteride effectively treats frontal hair loss with few side effects.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Prolactin affects when mice shed and grow hair.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Blocking a specific enzyme in male rat fetuses leads to the development of nipples and feminized genitalia.

Clomiphene citrate can reverse low hormone levels and symptoms in male runners with hypogonadotropic hypogonadism.

Puberty involves complex hormonal changes, varies by gender and ethnicity, and requires careful monitoring for abnormalities.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Finasteride works best in 6 months and lasts 6 years.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Finasteride can cause serious side effects in some men, needing more research for treatment.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Finasteride has a higher risk of reproductive side effects than minoxidil.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Minoxidil and finasteride can slow or halt hair loss, but may have side effects.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.